Univariate analysis on the results of treatments on 80 Non-Hodgkin's Lymphoma patients with CHOP (Cyciophosphamide, Doxorubicin, Vincristine, Prednisolone) therapy and DHAP (Dexamethasone, Cisplatin, Cytosar) therapy reveal that the factors that affect the Complete Remission, Overall survival, Disease-Free survival are: + B symptoms: No B symptoms is better than B symptoms.